Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0684249 (
lung carcinoma
)
23,830
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cancer/testis (CT) antigens exhibit highly tissue-restricted expression and are considered promising targets for cancer vaccines. Here we identified a novel CT gene
ZNF645
which restrictively expresses in normal human testes and lung cancer patients (68.3%). To investigate the promoter methylation status of
ZNF645
, we carried out bisulfite genomic sequencing and found that the CpG island in its promoter was heavily methylated in normal lung tissues without the expression of
ZNF645
, whereas there was high demethylation in normal human testes and
lung carcinoma
tissues with its expression. Also
ZNF645
could be remarkably activated in A549 and HEK293T cells treated by DNA demethylation agent 5'-aza-2'-deoxycytidine. And the dual luciferase assay revealed that the promoter activity of the
ZNF645
was inhibited by methylation of the CpG island region. Therefore, we proposed that
ZNF645
is a CT gene and activated in human testis and lung cancers by demethylation of its promoter region.
...
PMID:Promoter demethylation mediates the expression of ZNF645, a novel cancer/testis gene. 2058 29